Difficulty: Medium
Average Score: 67%
Practice
A patient with CHF on furosemide and digoxin developed UTI. Which antimicrobial should be avoided?
Correct answer
B
Rationale
In this scenario, the correct answer is B) Gentamicin. When a patient with congestive heart failure (CHF) is already on furosemide and digoxin, it is crucial to consider potential drug interactions. Gentamicin is a known nephrotoxic drug, meaning it can harm the kidneys. Since the patient is already on furosemide, which is a diuretic that can also affect kidney function, adding gentamicin could further compromise renal health. This can lead to worsening kidney function and exacerbate the patient's CHF.
Option A) Ampicillin is a broad-spectrum antibiotic but does not have the same nephrotoxic effects as gentamicin. Option C) Norfloxacin and Option D) Cotrimoxazole are both antibiotics that are not typically contraindicated in patients with CHF on furosemide and digoxin. However, gentamicin stands out as the most concerning choice due to its potential for renal toxicity.
Educationally, this question highlights the importance of considering potential drug interactions and contraindications when prescribing medications, especially in patients with complex medical conditions like CHF. It reinforces the need for healthcare providers to have a thorough understanding of pharmacology and how different drugs can interact with each other to ensure patient safety and optimal outcomes.
Option A) Ampicillin is a broad-spectrum antibiotic but does not have the same nephrotoxic effects as gentamicin. Option C) Norfloxacin and Option D) Cotrimoxazole are both antibiotics that are not typically contraindicated in patients with CHF on furosemide and digoxin. However, gentamicin stands out as the most concerning choice due to its potential for renal toxicity.
Educationally, this question highlights the importance of considering potential drug interactions and contraindications when prescribing medications, especially in patients with complex medical conditions like CHF. It reinforces the need for healthcare providers to have a thorough understanding of pharmacology and how different drugs can interact with each other to ensure patient safety and optimal outcomes.